0001209191-22-039103.txt : 20220624 0001209191-22-039103.hdr.sgml : 20220624 20220624091711 ACCESSION NUMBER: 0001209191-22-039103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220622 FILED AS OF DATE: 20220624 DATE AS OF CHANGE: 20220624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hambleton Julie CENTRAL INDEX KEY: 0001578771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40602 FILM NUMBER: 221037229 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Erasca, Inc. CENTRAL INDEX KEY: 0001761918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831217027 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 465-6511 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-22 0 0001761918 Erasca, Inc. ERAS 0001578771 Hambleton Julie C/O ERASCA, INC. 3115 MERRYFIELD ROW, SUITE 300 SAN DIEGO CA 92121 1 0 0 0 Stock Option (right to buy) 5.35 2022-06-22 4 A 0 40000 0.00 A 2023-06-22 2032-06-22 Common Stock 40000 40000 D 100% of the options to purchase shares vest on June 22, 2023, subject to the Reporting Person's continuous service to the Issuer on such vesting date. /s/ Ebun S. Garner, as Attorney-in-Fact 2022-06-24